Drug Trial Radar · NCT05741710
A Study to Assess the Use of Methylone in the Treatment of PTSD
Last checked: Nov 20, 2026Latest source record: Apr 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
79
Actual
Start
Mar 1, 2023
Primary completion
Feb 19, 2025
Study completion Feb 19, 2025
Sponsor
- Lead sponsor
- Transcend TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Feb 23, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is evaluating the safety, tolerability, and efficacy of methylone in adults with PTSD. The study will be conducted in two parts. * Part A is open-label and will enroll up to 15 participants with PTSD * Part B is randomized (1:1), double-blind, placebo-controlled and will enroll up to 64 participants with PTSD Eligible participants will enter a 4-week Treatment Period where they will receive methylone once weekly for 4 weeks (4 treatment sessions). Following the Treatment Period, participants will enter a 6-week Follow-up Period which includes 3 reflection visits (Week 4, 5, and 6) and a final study visit at Week 10.
Conditions
- Post Traumatic Stress Disorder
Interventions
MethyloneDrug
Methylone capsules, given orally, once a week for 4 weeks
PlaceboDrug
Placebo capsules to match methylone, given orally, once a week for 4 weeks. NOTE: Placebo is only in Part B
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in CAPS-5 Total Severity ScoreTime frame: up to 10 weeks
Locations
16 sites in 3 countries. Site status is shown where the registry gives one.
Mountain View Clinical Research
Denver, Colorado
Clinical Neuroscience Solutions - Jacksonville
Jacksonville, Florida
Accel Research Sites
Maitland, Florida
Sunstone Therapies
Rockville, Maryland
Boston Clinical Trials
Boston, Massachusetts
Cenexel HRI
Berlin, New Jersey
The Rivus Wellness & Research Institute
Oklahoma City, Oklahoma
Cedar Clinical Research
Murray, Utah
Tallaght Adult Mental Health Services
Dublin, Ireland
La Nua Day Hospital Mental Health Centre
Galway, Ireland
Cambridge University Hospitals NHS Foundation Trust
Cambridge, United Kingdom
Glasgow Clinical Research Facility, QEUH
Glasgow, United Kingdom
Clerkenwell Health
London, United Kingdom
King's College
London, United Kingdom
Oxford Health NHS Foundation Trust
Oxford, United Kingdom
Mirabilis Health
Belfast, Northern Ireland, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.